Bukit Sembawang Estates Ltd
SGX:B61
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Bukit Sembawang Estates Ltd
SGX:B61
|
SG |
|
Maha Properti Indonesia Tbk PT
IDX:MPRO
|
ID |
|
A
|
Aurinia Pharmaceuticals Inc
F:IKAP
|
CA |
Wall St Price Targets
B61 Price Targets Summary
Bukit Sembawang Estates Ltd
According to Wall Street analysts, the average 1-year price target for B61 is 6 SGD with a low forecast of 5.94 SGD and a high forecast of 6.17 SGD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is B61's stock price target?
Price Target
6
SGD
According to Wall Street analysts, the average 1-year price target for B61 is 6 SGD with a low forecast of 5.94 SGD and a high forecast of 6.17 SGD.
What is the Revenue forecast for Bukit Sembawang Estates Ltd?
Projected CAGR
35%
Over the last 14 years, the compound annual growth rate for Revenue has been -1%. The projected CAGR for the next 1 year is 35%.
What is the Gross Profit forecast for Bukit Sembawang Estates Ltd?
Projected CAGR
-32%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 0%. The projected CAGR for the next 1 year is -32%.
What is the Operating Income forecast for Bukit Sembawang Estates Ltd?
Projected CAGR
-34%
Over the last 14 years, the compound annual growth rate for Operating Income has been -2%. The projected CAGR for the next 1 year is -34%.
What is the Pre-Tax Income forecast for Bukit Sembawang Estates Ltd?
Projected CAGR
-25%
Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been -2%. The projected CAGR for the next 1 year is -25%.
What is the Net Income forecast for Bukit Sembawang Estates Ltd?
Projected CAGR
-24%
Over the last 14 years, the compound annual growth rate for Net Income has been -2%. The projected CAGR for the next 1 year is -24%.
